EXAGEN
Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. Exagenโs goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including rheumatoid arthritis and lupus. Exagen was established in 2002 and is headquartered in Vista, California.
EXAGEN
Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical
Founded:
2002-01-01
Address:
Vista, California, United States
Country:
United States
Website Url:
http://www.exagen.com
Total Employee:
101+
Status:
Active
Contact:
888-452-1522
Email Addresses:
[email protected]
Total Funding:
322.63 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
ArrePath
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Innovatus Capital Partners
Innovatus Capital Partners investment in Post-IPO Debt - Exagen
J. Hunt Holdings
J. Hunt Holdings investment in Venture Round - Exagen
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners investment in Venture Round - Exagen
Sun Mountain Capital
Sun Mountain Capital investment in Venture Round - Exagen
Tullis Health Investors
Tullis Health Investors investment in Venture Round - Exagen
Innovatus Capital Partners
Innovatus Capital Partners investment in Debt Financing - Exagen
Cottonwood Technology Fund
Cottonwood Technology Fund investment in Debt Financing - Exagen
Tullis Health Investors
Tullis Health Investors investment in Debt Financing - Exagen
Sun Mountain Capital
Sun Mountain Capital investment in Debt Financing - Exagen
CRG
CRG investment in Debt Financing - Exagen
Official Site Inspections
http://www.exagen.com Semrush global rank: 3.09 M Semrush visits lastest month: 5.19 K
- Host name: 36.42.202.35.bc.googleusercontent.com
- IP address: 35.202.42.36
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York

More informations about "Exagen"
Exagen - Crunchbase Company Profile & Funding
Exagenโs goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and โฆSee details»
Investor Relations | Exagen
Mar 11, 2025 Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025 โฆSee details»
Exagen Org Chart + Executive Team - The Official Board
Organizational Chart of Exagen. Exagen Org Chart www.exagen.com. has 13 executives +1 โฆSee details»
Exagen - businessabc.net
Feb 25, 2025 Exagen Inc. develops and commercializes various testing products based on its โฆSee details»
Exagen Inc. Company Profile | Vista, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Exagen Inc. โฆSee details»
Exagen Company Profile - Office Locations, Competitors, Revenue โฆ
Oct 29, 2024 Exagen has 1 employees at their 1 location and $55.64 m in annual revenue in โฆSee details»
Exagen Inc. - AnnualReports.com
Exagen Inc. reports have an aggregate usefulness score of 4.8 based on 142 reviews. Exagen Inc. Most Recent Annual Report. MOST RECENT 2023 Annual Report and Form 10K. View PDF View Form 10K (HTML) View 2022 ESG โฆSee details»
Leadership โ Exagen Inc.
Prior to joining Exagen, Mr. Black served as CFO of Standard BioTools, where he played a key โฆSee details»
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 โฆ
Dec 31, 2024 About Exagen. Exagen is a leading provider of autoimmune testing and its โฆSee details»
Contact Us - Exagen Inc.
Contact Us Exagen Inc. is committed to providing excellent service to our physicians, patients โฆSee details»
Autoimmune Disease Testing Lab - Life Sciences Company
About Exagen Inc. Exagen is dedicated to transforming the care continuum for patients โฆSee details»
Transforming energy for good - Exagen
Our end-to-end approach means Exagen are on the ground every step of the way, developing, โฆSee details»
Investor Relations | Exagen
Apr 21, 2025 Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors โฆSee details»
Exagen Group - Org Chart, Teams, Culture & Jobs - The Org
View Exagen Group's up-to-date org chart, open roles, and culture details. Find executives, โฆSee details»
Q1 2025 Exagen Inc Earnings Call - Yahoo Finance
1 day ago Earlier today, Exagen Inc released financial results for the quarter ended March 31, โฆSee details»
Exagen Company Profile - Office Locations, Competitors, Revenue โฆ
Exagen has 5 employees at their 1 location and $34.1 m in total funding,. See insights on โฆSee details»
Exagenโs Proprietary Biomarker Technology Enables Physicians to โฆ
Exagen and collaborators spent five years validating the Avise CTD test (the name refers to โฆSee details»
Earnings call transcript: Exagen Inc. Q1 2025 revenue beats โฆ
1 day ago Exagen Inc. reported a record revenue of $15.5 million for Q1 2025, beating the โฆSee details»
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in โฆ
Mar 31, 2025 Exagenโs commercial success depends upon attaining and maintaining โฆSee details»
Exagen Group - Crunchbase Company Profile & Funding
Exagen Group may be growing as it has recently received approval for a 20MW energy storage โฆSee details»